Zobrazeno 1 - 10
of 3 983
pro vyhledávání: '"Nosocomial pneumonia"'
Autor:
Pierre Bay, Vincent Fihman, Paul-Louis Woerther, Bastien Peiffer, Ségolène Gendreau, Romain Arrestier, Pascale Labedade, Elsa Moncomble, Antoine Gaillet, Guillaume Carteaux, Nicolas de Prost, Armand Mekontso Dessap, Keyvan Razazi
Publikováno v:
Annals of Intensive Care, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Background Antimicrobial stewardship (AMS) for ventilator-associated pneumonia (VAP) or ventilated hospital-acquired pneumonia (vHAP) in extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) carriers is challenging. BioFire® Fi
Externí odkaz:
https://doaj.org/article/42e2ea9e17e34b4a97a585fb27705e79
Autor:
Ryan K. Shields, Juan P. Horcajada, Shweta Kamat, Paurus M. Irani, Margaret Tawadrous, Tobias Welte
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 7, Pp 1639-1664 (2024)
Abstract Introduction Ceftazidime-avibactam (CAZ-AVI) is a combination of the third-generation cephalosporin ceftazidime and the novel, non-β-lactam β-lactamase inhibitor avibactam that is approved for the treatment of pediatric (≥ 3 months) and
Externí odkaz:
https://doaj.org/article/27b528581cc349a1ae69061d90b019cf
Autor:
David Luque Paz, Dara Chean, Pierre Tattevin, Damien Luque Paz, Betsega Assefa Bayeh, Achille Kouatchet, Delphine Douillet, Jérémie Riou
Publikováno v:
Annals of Intensive Care, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Background Multiple randomized controlled studies have compared numerous antibiotic regimens, including new, recently commercialized antibiotics in the treatment of nosocomial pneumonia (NP). The objective of this Bayesian network meta-analy
Externí odkaz:
https://doaj.org/article/ecf8d537723647fb985da8c49e1a782c
Autor:
Rachina S.A., Fedina L.V., Alkhlavov A.A., Gasanova D.R., Zainalabidova Kh.G., Koval A.A., Burmistrova E.N., Savochkina Yu.A., Sychev I.N., Kuleshov V.G., Larin E.S.
Publikováno v:
Клиническая микробиология и антимикробная химиотерапия, Vol 26, Iss 1, Pp 104-112 (2024)
Nosocomial pneumonia is one of the most common healthcare-associated infections and the most frequent in intensive care unit (ICU) patients. The clinical and economic consequences of nosocomial pneumonia are very significant, especially for ventilate
Externí odkaz:
https://doaj.org/article/e4380e375e844e52965970a5c6c06714
Publikováno v:
Healthcare in Low-resource Settings (2024)
Inhalation nebulization therapy is important for administering medications to patients in aerosolized form. However, there are persistent apprehensions in healthcare settings regarding aerosol contamination because of the significant infection risk.
Externí odkaz:
https://doaj.org/article/56d176720cb44975b3eda4f9501b4d59
Autor:
Sheng-Huei Wang, Chi-Kang Teng, Ming-Cheng Chan, Kuang-Yao Yang, Chau-Chyun Sheu, Shinn-Jye Liang, Wei-Hsuan Huang, Jia-Yih Feng, Chia-Min Chen, Zi-Xeng Weng, Chung-Kan Peng
Publikováno v:
International Journal of Infectious Diseases, Vol 146, Iss , Pp 107128- (2024)
Objectives: This study analyzed the risk and impact of developing pneumogenic bacteremia in patients with CRAB nosocomial pneumonia in ICU. Methods: This is multicenter retrospective study. Clinical outcomes were compared between bacteremia and non-b
Externí odkaz:
https://doaj.org/article/35dc8c6457c44a33a4fe732a8efe9537
Publikováno v:
Infectious Disease Reports, Vol 16, Iss 2, Pp 228-238 (2024)
Non-ventilator associated hospital-acquired pneumonia (nvHAP) is a common nosocomial infection, but little is known about the outcomes of patients with nvHAP and the risk factors for adverse outcomes. In this retrospective study conducted in a Swiss
Externí odkaz:
https://doaj.org/article/0fbf090feb3f4b2aac8dda1916055500
Publikováno v:
Microbes and Infectious Diseases, Vol 5, Iss 1, Pp 270-281 (2024)
Background: Drug-resistant bacteria are major determinants of hospital-acquired infections that are particularly troublesome in intensive care units (ICU). Klebsiella pneumoniae (K. pneumoniae) is one of the most prevalent causes of nosocomial pneumo
Externí odkaz:
https://doaj.org/article/21c83071eb274b8996c9dce84adf3895
Publikováno v:
International Journal of Infectious Diseases, Vol 140, Iss , Pp 92-94 (2024)
Pseudomonas fluorescens (P. fluorescens) is not generally considered a bacterial pathogen in humans; however, multiple culture-based and culture-independent studies have identified it in the indigenous microbiota of multiple body sites. We herein rep
Externí odkaz:
https://doaj.org/article/479da2a1ed3240a4aaa596d701cf8e0f
Autor:
Svetlana А. Rachina, Ludmila V. Fedina, Marina V. Sukhorukova, Igor N. Sychev, Egor S. Larin, Abdulbari A. Alkhlavov
Publikováno v:
Терапевтический архив, Vol 95, Iss 11, Pp 996-1003 (2023)
Nosocomial pneumonia is a healthcare-associated infection with significant consequences for the patient and the healthcare system. The efficacy of treatment significantly depends on the timeliness and adequacy of the antibiotic therapy regimen. The g
Externí odkaz:
https://doaj.org/article/83732a0651814787b47bceb5efb431e1